Castle Biosciences (CSTL) EPS (Diluted) Growth (1y) (2019 - 2026)
Castle Biosciences (CSTL) EPS (Diluted) Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 10.71% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 59.30% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 36.90% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 58.79% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | -6.55% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 17.55% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | -9.61% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 18.37% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 28.42% |
| 10 | Castle Biosciences | 1.04 Bn | 773.13 Mn | 79.85 Mn | -143.94% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -143.94% |
| Mar 31, 2026 | 46.22% |
| Dec 31, 2025 | -124.54% |
| Sep 30, 2025 | -122.33% |
| Jun 30, 2025 | -50.31% |
| Mar 31, 2025 | -879.97% |
| Dec 31, 2024 | 440.54% |
| Sep 30, 2024 | 129.99% |
| Jun 30, 2024 | 144.19% |
| Mar 31, 2024 | 91.60% |
| Dec 31, 2023 | 87.84% |
| Sep 30, 2023 | 66.56% |
| Jun 30, 2023 | -1,010.87% |
| Mar 31, 2023 | -13.33% |
| Dec 31, 2022 | -48.66% |
| Sep 30, 2022 | -65.02% |
| Jun 30, 2022 | 81.95% |
| Mar 31, 2022 | -463.72% |
| Dec 31, 2021 | -106.10% |
| Sep 30, 2021 | -102.57% |